Exhibit 5.1 A Clinical Development Timeline for Shiva 102
EX-10.3 4 v239557_ex10-3.htm EXHIBIT 10.3
Exhibit 5.1 A
Clinical Development Timeline for Shiva 102
The following clinical development timeline provides a detailed timeline for the next *** and general outline for subsequent development. Details of the Development Plan are contained in the CorMedix Global Development Plan for Deferiprone dated as of the effective date of Amendment 3 and attached hereto as Exhibit 5.1 B.
| 2011 | |
| *** | |
| *** | |
| *** | |
| *** | |
| *** | |
| *** | |
| *** | |
| *** | |
| *** | |
| *** | |
| *** | |
| *** | |
| *** | |
| *** | |
| *** | |
| *** | |
| *** | |
| *** | |
| *** | |
| *** | |
| *** | |
Exhibit 5.1 A
Clinical Development Timeline for Shiva 102
The following clinical development timeline provides a detailed timeline for the next *** and general outline for subsequent development. Details of the Development Plan are contained in the CorMedix Global Development Plan for Deferiprone dated as of the effective date of Amendment 3 and attached hereto as Exhibit 5.1 B.
| 2012 | ||
| *** | ||
| *** | ||
| *** | ||
| *** | ||
| *** | ||
| *** | ||
| *** | ||
| *** | ||
| *** | ||
| *** | ||
| *** | ||
| *** | ||
| *** | ||
| *** | ||
| *** | ||
| *** | ||
| *** | ||
| *** | ||
| *** | ||
